Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
A study consisting of a dose-escalation phase and a dose-expansion phase to evaluate the safety, tolerability, pharmacokinetics, and efficacy of venetoclax in combination with atezolizumab, carboplatin, and etoposide.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Dose Escalation, Maintenance Arm A:
Dose Escalation, Induction Arm B:
Dose Expansion, Maintenance-Only:
Dose Escalation (Arms A and B) and Dose Expansion:
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
2 participants in 8 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal